An Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1.Xx_NEWLINE_xXPatients must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1\r\n* NOTE: Participants with impaired decision-making capacity (IDMC) should not be allowed to participate in this study due to its complexityXx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status 0, 1, 2Xx_NEWLINE_xXPatients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0-2; ECOG performance status (PS) 3 will be permitted if the decreased PS is attributed to the lymphomaXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXSubject has an Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 1.Xx_NEWLINE_xXHave a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of zero to two unless decline is due to bony diseaseXx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status > 2Xx_NEWLINE_xXSubjects must have an Eastern Cooperative Oncology Group (ECOG) performance score =< 3 (Karnofsky >= 30)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 to 2 for Dose Escalation phase and ECOG PS 0 to 1 for Dose Expansion phaseXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status score of 0, 1, or 2Xx_NEWLINE_xXEastern Co-Operative Group (Eastern Cooperative Oncology Group [ECOG]) performance score of 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale up to 14 days before treatment initiationXx_NEWLINE_xXPatients with an Eastern Cooperative Oncology Group (ECOG) score of =< 2 or Karnofsky score of >= 50Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPerformance status 0-1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 1 at screening.Xx_NEWLINE_xXSubject has an Eastern Cooperative Oncology Group performance score (ECOG) ? 2Xx_NEWLINE_xXPerformance status (PS) 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXHave a performance status of ?1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXHas a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale.Xx_NEWLINE_xXHave a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group performance status (ECOG PS) score of 0 or 1Xx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance ScaleXx_NEWLINE_xXMust have Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-2Xx_NEWLINE_xXEastern Cooperative Group (ECOG) performance scale 0-1Xx_NEWLINE_xXZubrod (Eastern Co-operative Oncology Group [ECOG]) Performance Status (PS) of 0-1.Xx_NEWLINE_xXMust have an Eastern Cooperative Oncology Group (ECOG) performance status score 0, 1, or 2Xx_NEWLINE_xXEastern Collaborative Oncology Group (ECOG) Performance Status of 0-1 (Appendix 1).Xx_NEWLINE_xXHave a performance status of ?1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXGynecologic Oncology Group (GOG) or Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky scale (KPS) =< 70%Xx_NEWLINE_xXPerformance status score of 0-2 according to the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXAn Eastern Cooperative Oncology Group (ECOG) performance score 0-2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1.Xx_NEWLINE_xXHas a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale.Xx_NEWLINE_xXSubject has a performance status (PS) of 0-2 according to the Eastern Cooperative Oncology Group (ECOG) scale. Subjects with ECOG PS of 3 may be included if decreased PS is secondary to DLBCL only, and not to comorbidities.Xx_NEWLINE_xXMust have a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXPatients with an Eastern Cooperative Oncology Group (ECOG) score of ? 2 or Karnofsky score of ? 50Xx_NEWLINE_xXHave a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-2.Xx_NEWLINE_xXHas an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0 – 2 (asymptomatic to symptomatic but capable of self-care) within 45 days prior to randomizationXx_NEWLINE_xXEastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0, 1, or 2 (For patients enrolling in the atezolizumab arm, ECOG score must be documented within 7 days prior to first treatment.)Xx_NEWLINE_xXMust have Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1, assessed within 14 days prior to randomization. Two observers qualified to perform assessment of the performance status will be required to perform this assessment. If discrepant, the one with the most deteriorated performance status will be considered true.Xx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 3 days prior to first dose of pembrolizumabXx_NEWLINE_xXEastern Collaborative Oncology Group (ECOG) performance status of 0 or 1 at screeningXx_NEWLINE_xXEastern Collaborative Oncology Group (ECOG) Performance Status of ?2Xx_NEWLINE_xXHave a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXHave a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-2, inclusively or Lansky score ? 60, as age appropriateXx_NEWLINE_xXPerformance status 0 or 1 on Eastern Cooperative Oncology Group Performance Scale.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0-1 with no clinical deterioration over the previous 2 weeks and likely able to complete at least 9 weeks of treatment.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group score of 0 or 1.Xx_NEWLINE_xXPerformance status 0 or 1 on Eastern Cooperative Oncology Group Performance Scale.Xx_NEWLINE_xXMust have Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2.Xx_NEWLINE_xXEastern co-operative oncology group (ECOG) performance score </=2 at screening Further inclusion criteria applyXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0–2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score ? 2Xx_NEWLINE_xXEastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1. 4. Subjects must have adequate hematopoietic, liver, renal and coagulation function as assessed by specific laboratory criteria.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status =< 2; performance status of 3 will be accepted if impairment is caused by DLBCL complications and improvement is expected once therapy is initiatedXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXECOG (Eastern Cooperative Oncology Group) performance score of 1 or 0. Subjects in the Phase 2 portion: ECOG performance score of 2, 1, or 0.Xx_NEWLINE_xXHave a performance status of at least 1 on the Eastern Cooperative Oncology Group (ECOG) scale and life expectancy >6 monthsXx_NEWLINE_xXPatients must have an Eastern Cooperative Oncology Group (ECOG) performance score of 0-1Xx_NEWLINE_xXPatients must have a performance status of 0 or 1 Eastern Cooperative Oncology Group (ECOG) performance status (PS) scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-1Xx_NEWLINE_xXPerformance status ? 3 (Eastern Cooperative Oncology Group [ECOG] scale)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 2 or better.Xx_NEWLINE_xXHave a performance status of 0 or 1 on Eastern Cooperative Oncology Group (ECOG) Performance Scale;Xx_NEWLINE_xXHave an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. Evaluation of ECOG is to be performed within 7 days prior to the date of allocation/randomizationXx_NEWLINE_xXPatient must have an Eastern Cooperative Oncology Group (ECOG) performance score of =< 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 or 1Xx_NEWLINE_xXClinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 at enrollment and within 7 days of initiating lymphodepleting chemotherapy.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXAn Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 and a minimum life expectancy of 12 weeksXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXHas an Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 orXx_NEWLINE_xXEastern Cooperative Group ECOG) Performance Status score of 0 or 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score (0 and 1)Xx_NEWLINE_xXPerformance status (PS) of 0-2 on the Eastern Cooperative Oncology Group (ECOG) scale. Note: PS 2 patients can only participate if, in the assessment of the clinical investigator, and with the consent of the medical monitor, the patient has the ability to participate in the clinical study for a minimum of at least 2 cycles.Xx_NEWLINE_xXPerformance status 0-1 (by Eastern Cooperative Oncology Group [ECOG] scale)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXHave a performance status (PS) of ?1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale or > 70% on the Karnofsky scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXECOG (Eastern Cooperative Oncology Group) performance status score of 0 – 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) (World Health Organization [WHO]/Gynecologic Oncology Group [GOG]/Zubrod score) performance status 0 - 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale.Xx_NEWLINE_xXHave a performance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPatients must be medically fit to undergo surgery as determined by the treating medical and surgical oncology team and have Eastern Cooperative Oncology Group (ECOG) performance status 0-2.Xx_NEWLINE_xXHave a performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXHave a performance status of 0, to 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale; for purposes of HCT, this will correspond to a Karnofsky performance status of >= 80%Xx_NEWLINE_xXHave a performance status of 0 to 1 on the Eastern Cooperative Oncology Group scale.Xx_NEWLINE_xXHave a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXHave a performance status of 0 or 1 using the Eastern Cooperative Oncology Group (ECOG) performance scale within 3 days of first dose of study drugXx_NEWLINE_xXPerformance status =< 2 (Eastern Cooperative Oncology Group [ECOG] scale).Xx_NEWLINE_xXAn Eastern Cooperative Oncology Grou (ECOG) performance status score of 0, 1, or 2.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXECOG (Eastern Cooperative Oncology Group) performance status score of 0 – 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0-3, however grade 4 patients may be enrolled at the discretion of the treating radiation oncologistXx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status 0, 1, or 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status =< 2 for patients treated in the expansion phase; ECOG performance status (PS) =< 1 is required for participants in the dose-finding portion of the studyXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score 0-1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0 or 1.Xx_NEWLINE_xXPatient Eastern Cooperative Oncology Group (ECOG) of 0-2, with life expectancy of at least 6 monthsXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score 0-1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPerformance status =< 2 (Eastern Cooperative Oncology Group [ECOG] scale).Xx_NEWLINE_xXPatients must exhibit an Eastern Cooperative Oncology Group (ECOG) status of 0-2\r\n* NOTE: ECOG performance status 3 will be allowed only if thought to be directly secondary to adenoid cystic carcinoma disease by treating physicianXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score =< 2.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPerformance status of =< 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXMust be ambulatory, with an Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1.Xx_NEWLINE_xXMust have an Eastern Cooperative Oncology Group (ECOG) Performance Score of 0 - 2.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPatients must have Eastern Cooperative Oncology Group (ECOG) performance status score of =< 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0 to 2; (performance status of 3 will be allowed if poor performance status is thought to be directly secondary to ALL)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0 or 1 with no deterioration over the previous 2 weeks and an estimated life expectancy of greater than 12 weeksXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score less than or equal to (</=) 2Xx_NEWLINE_xXAn Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0, 1 or 2.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; patients with an ECOG performance status of 2 will be allowed at the discretion of the treating investigator in agreement with the sponsor-investigatorXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXSubjects must have a performance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHas an Eastern Cooperative Oncology Group (ECOG) performance score (PS) score of 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHas a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score: 0 to 1Xx_NEWLINE_xXPatients with Eastern Cooperative Oncology Group performance scale (ECOG PS) 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 using the Eastern Cooperative Oncology Group (ECOG) performance scale within 7 days of first dose of study drugXx_NEWLINE_xXHave Eastern Cooperative Oncology Group (ECOG) scale performance status of 0 or 1.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0-3Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-1Xx_NEWLINE_xXHave a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale at the time of screeningXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPerformance score of >= 70 by Karnofsky/Lansky or performance score (PS) 0 to 1 (Eastern Cooperative Oncology Group [ECOG] =< 1)Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of =< 2 and fit for induction therapy in the opinion of the treating physicianXx_NEWLINE_xXHistory/physical examination, including breast exam and documentation of weight and Eastern Cooperative Oncology Group (ECOG) performance statusXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score must be =< 2 within two weeks prior to registrationXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXHave a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXThe subject must have a performance status of 0-1 as determined by criteria set forward by the Eastern Cooperative Oncology GroupXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of =< 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHas a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPatients must have a performance status of 0 - 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status (PS):\r\n* Group I: =< 2\r\n* Group II: =< 3\r\n* ECOG PS of 4 will be allowed in Group II only if symptoms due to pulmonary KS; (with Karnofsky = 20%)Xx_NEWLINE_xXPatients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2Xx_NEWLINE_xXHave a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPatients must have a performance status of 0-2 (Eastern Cooperative Oncology Group [ECOG] scale)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 2 or betterXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status =< 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance ScaleXx_NEWLINE_xXPerformance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale (PS)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXHave an Eastern Cooperative Oncology Group (ECOG) Performance score =< 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score 0Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale at study entryXx_NEWLINE_xXAdequate blood cell counts, kidney function, liver function and Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 (for the Recommended Phase 2 Cohort, a ECOG score of 2 may be allowed on a case-by-case basis)Xx_NEWLINE_xXHave an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1. Subjects with ECOG 2 may be considered for enrollment in Parts C, D, F, and H if approved by Medical MonitorXx_NEWLINE_xXEastern Cooperative Oncology Group performance status must be 0 or 1, and life expectancy should be approximately 5 months or more.Xx_NEWLINE_xXUnlimited number of prior treatment lines, provided Gynecologic Oncology Group (GOG)/Eastern Cooperative Oncology Group (ECOG) status is 0-1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 2 or lessXx_NEWLINE_xXPerformance status must be Eastern Cooperative Oncology Group (ECOG) performance scale (PS) 0, 1, or 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXThe subject must have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-2 (Appendix 3).Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2; patients with a PS of 3 are eligible if the performance status is due to their malignancy, and not a co-morbid medical condition (example [ex]: perineal pain impacting their ability to sit or ambulate, etc.)Xx_NEWLINE_xXHas a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 or 2 on the Eastern Cooperative Oncology Group (ECOG)\r\nperformance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXINCLUSION CRITERIA FOR ADDITIONAL PTCy-MILs INFUSION AT RELAPSE: Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky performance scale (KPS) >= 70%Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPatient must have performance status =< 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of < or =< 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0–2 (3 if it is directly disease related and is expected to get better if the acute lymphoblastic leukemia/lymphoma [ALL] is under control)Xx_NEWLINE_xXPatients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (performance status of 2 will be allowed if poor performance status is thought to be directly secondary to patient’s Hodgkin lymphoma [HL])Xx_NEWLINE_xXZubrod performance status =< 3 (Eastern Cooperative Oncology Group [ECOG] scale)Xx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status =< 2Xx_NEWLINE_xXPatients must have Eastern Cooperative Oncology Group (ECOG) performance status score of =< 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0-2Xx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance ScaleXx_NEWLINE_xXAdequate performance status (Eastern Cooperative Oncology Group [ECOG] < 3) and research participant does not require mechanical ventilationXx_NEWLINE_xXPatient must have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score 0 - 2Xx_NEWLINE_xXAll case Eastern Cooperative Oncology Group (ECOG) performance score equal to or less than 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score (PS) of 0-2Xx_NEWLINE_xXPerformance status (World Health Organization [WHO]/Eastern Cooperative Oncology Group [ECOG] scale) 0-2Xx_NEWLINE_xXClinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-2 within 30 days of signing informed consent (Turnstile I)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of =< 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network (ACRIN) performance status between 0-2Xx_NEWLINE_xXPatient eligible for standard induction chemotherapy based on Eastern Cooperative Oncology Group (ECOG) performance status (PS) and vital organ function at the discretion of the treating physicianXx_NEWLINE_xXSubjects must have an Eastern Cooperative Oncology Group (ECOG) scale of 0-2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score must be =< 2 within two weeks prior to registrationXx_NEWLINE_xXClinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-2 within 30 days of signing informed consent (Turnstile I)Xx_NEWLINE_xXPatient must have performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale and life expectancy > 3 monthsXx_NEWLINE_xXPatient must have performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale and life expectancy > 3 monthsXx_NEWLINE_xXPatients must have an Easter Cooperative Oncology Group (ECOG) score equal to or less than 2Xx_NEWLINE_xXSouthwest Oncology Group (SWOG)/Eastern Cooperative Oncology Group (ECOG) performance score >= 2Xx_NEWLINE_xXPerformance status =< 2 (Eastern Cooperative Oncology Group [ECOG] scale)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of less than or equal toXx_NEWLINE_xXPerformance status 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXHas an Eastern Cooperative Oncology Group (ECOG) PS score of 0 or 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status Score 0 - 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status =< 2 and life expectancy greater than 12 weeks based on the investigator's clinical judgmentXx_NEWLINE_xXPatients with an Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1Xx_NEWLINE_xXParticipants will not be excluded based on performance status; for patients with Eastern Cooperative Oncology Group (ECOG) performance status >= to 3 the dosing schedule will be discussed with study chairmanXx_NEWLINE_xXPatients > 70 may be considered if performance status > 80% or Eastern Cooperative Oncology Group (ECOG) =< 1 and comorbidity score < 3; these patients must be discussed with the principal investigator (PI), Rachel Salit prior to enrollmentXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score 0 - 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status Score 0-2Xx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave an Eastern Cooperative Oncology Group (ECOG) score of 0, 1, or 2.Xx_NEWLINE_xXEaster Cooperative Oncology Group (ECOG) Performance Status ? 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXPatient has a performance status (PS) of 0-2 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXGynecological Oncology Group (GOG) performance status =< 2Xx_NEWLINE_xXHas a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale.Xx_NEWLINE_xXHave a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern cooperative oncology group (ECOG) performance score of 0 or 1Xx_NEWLINE_xXEastern Cooperative oncology Group (ECOG) performance status score ? 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0?1Xx_NEWLINE_xXEastern Cooperative Oncology Group performance score 0 to 2;Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0, 1 or 2Xx_NEWLINE_xXGynecologic Oncology Group (GOG) Performance Status of 0, 1, or 2Xx_NEWLINE_xXSubjects must have an Eastern Cooperative Oncology Group (ECOG) performance status score = 0 or 1Xx_NEWLINE_xXSubjects who have a performance status of ?2 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0-1Xx_NEWLINE_xXORAL CAVITY SQUAMOUS CELL CARCINOMA COHORT: Eastern Cooperative Oncology Group (ECOG) performance status < 2Xx_NEWLINE_xXEastern Cooperative Oncology Group performance status score of 0 or 1.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of =< 3 and fit for induction therapy in the opinion of the treating physicianXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0-1.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 - 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance ScaleXx_NEWLINE_xXFOR TISSUE COLLECTION TO ESTABLISH PDX (PART 1): Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.Xx_NEWLINE_xXPatient has an Eastern Cooperative Oncology Group performance status (ECOG PS) =< 1 that the investigator believes is stable at the time of screening.Xx_NEWLINE_xXThe participant must have an Eastern Cooperative Oncology Group (ECOG) score between 0 - 2 at screeningXx_NEWLINE_xXPatient has an Eastern Cooperative Oncology Group Performance Status (ECOG PS) =< 1 that the investigator believes is stable at the time of screeningXx_NEWLINE_xXPerformance status </=2 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0, 1 or 2Xx_NEWLINE_xXThe subject must have a performance status of 0-2 as determined by criteria set forward by the Eastern Cooperative Oncology GroupXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group performance score (ECOG) ? 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score less than or equal to (</=) 2Xx_NEWLINE_xXPatient has an Eastern Cooperative Oncology Group (ECOG) performance status score ? 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status >= 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-1Xx_NEWLINE_xXPatients must have a performance status of =< 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1\r\n* Patients with ECOG PS of 2, secondary to the underlying disease, may be enrolledXx_NEWLINE_xXEaster Cooperative Oncology Group (ECOG) performance status 0-2Xx_NEWLINE_xXHas a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale; (>= 70% Karnofsky performance score)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) 0, 1 or 2, or for children =< 10 years of age, Lansky >= 60Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at initial enrollment, as assessed by clinician or investigatorXx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status of 0 or 1Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0-1Xx_NEWLINE_xXECOG (Eastern Cooperative Oncology Group) Performance Score ? 1.Xx_NEWLINE_xXAsymptomatic or minimally symptomatic disease as demonstrated by Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 and no need for opiate pain medications to control pain/symptomsXx_NEWLINE_xXPerformance Status: Eastern Cooperative Oncology Group (ECOG) 0-1 unless mobility is limited from chronic physical handicapXx_NEWLINE_xXPerformance status (PS) 0, 1, or 2 per the Eastern Cooperative Oncology Group (ECOG) performance status scale (Karnofsky performance score >= 50%)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXPatients must have Eastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network (ACRIN) performance status of 0-2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-2Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-2.Xx_NEWLINE_xXParticipant must have an Eastern Cooperative Oncology Group (ECOG) performance score of 0 - 1.Xx_NEWLINE_xXHas a performance status of 0 or 1 using the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 7 days of first dose of study drug.Xx_NEWLINE_xXHas a performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale for Cohorts A and C and a performance status of 0 or 1 for Cohort B within 10 days of study startXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score (PS) <2.Xx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale.Xx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 3 days prior to first dose of study medicationXx_NEWLINE_xXperformance status (PS) of 0 to 1 on the Eastern Cooperative Oncology Group scaleXx_NEWLINE_xXParticipant must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXAn Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1.Xx_NEWLINE_xXHas performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) Performance ScaleXx_NEWLINE_xXHas performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance ScaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 to 1Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXHas a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance ScaleXx_NEWLINE_xXEastern Collaborative Oncology Group (ECOG) performance score of less than or equal toXx_NEWLINE_xXHave a performance status of 0 to 2 on the Eastern Cooperative Oncology Group (ECOG) scale for adults.Xx_NEWLINE_xXPatients with Gynecologic Oncology Group (GOG) performance status of 0 or 1 OR Eastern Cooperative Oncology Group (ECOG) PS of 0 or 1 OR Karnofsky performance status (PS) >= 80%Xx_NEWLINE_xXEastern Cooperative Oncology Group score ? 2Xx_NEWLINE_xXParticipant must have an Eastern Cooperative Oncology Group (ECOG) Performance Score of 0 to 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 to 2.Xx_NEWLINE_xXHas performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance status less than or equal to (</=) 2 (for dose-escalation part) and 0 or 1 (for dose-expansion part)Xx_NEWLINE_xXEastern Cooperative Oncology Group performance status score of 0, 1, or 2Xx_NEWLINE_xXHave a performance status of less than or equal to 1 on the Eastern Cooperative Oncology Group (ECOG) scale and life expectancy of more than 12 weeks.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXMust have Eastern Cooperative Oncology Group (ECOG) Performance score of 0, 1, or 2.Xx_NEWLINE_xXPerformance status ? 2 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status scaleXx_NEWLINE_xXPatients with Gynecologic Oncology Group (GOG) performance status of 3 or 4Xx_NEWLINE_xXPatients must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) at 0, 1, 2; (i.e. the patient must be able to care for himself/herself with only occasional help from others)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of ? 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score less than or equal to 2Xx_NEWLINE_xXhave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group scaleXx_NEWLINE_xXHas a performance status of 0 or 1 using the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 7 days of first dose of study drugXx_NEWLINE_xXPerformance status with Eastern Cooperative Oncology Group (ECOG) score =< 2; patients with performance status of 3 may be considered as long as the decline has been of short duration (< 1 month), and is due to their malignancy and not a comorbid condition (example: pain limiting activity)Xx_NEWLINE_xXECOG (Eastern Cooperative Oncology Group) Performance Status of 0-2 within 28 days prior to registration. ECOG Performance Status of 3 will only be allowed if judged by the treating investigator as attributable exclusively to bone pain.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXParticipant must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score < 2Xx_NEWLINE_xXSubjects with Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXHave a confirmed diagnosis of intermediate or high-risk SMM, and an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group scale at baseline.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status ?1 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXEastern Cooperative Oncology Group performance status of 0 to1. For LM patients, 0 to 2 is acceptable.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score 0-1Xx_NEWLINE_xXHave a performance status (PS) of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXMust have an Eastern Cooperative Oncology Group Performance Status score of 0, 1, or 2Xx_NEWLINE_xXHave a performance status ?1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXSubjects with Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of less than equal to (</=) 1Xx_NEWLINE_xXEastern Co-Operative Group (ECOG) performance status = 0 - 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 or 1Xx_NEWLINE_xXSubject has an Eastern Cooperative Oncology Group (ECOG) score of 0 1 or Karnofsky Performance Status Score ? 70.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXHave a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEaster Cooperative Oncology Group (ECOG) performance status 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status of 0 to 1.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score 0-1Xx_NEWLINE_xXHave a performance status ?1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status score of 0 to 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance of 0-2 with anticipated life expectancy of >= 12 weeksXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance scale status of 0 or 1Xx_NEWLINE_xXPatients must have a performance status score of 0, 1 or 2 by Eastern Cooperative Group (ECOG) criteria.Xx_NEWLINE_xXPerformance status 0-1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXEastern Cooperative Oncology Group performance status (ECOG PS) score of 0-1.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0, 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score ? 2Xx_NEWLINE_xXHave a performance status of =< 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXHave a performance status of < 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status of =< 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group performance score of 0 or 1Xx_NEWLINE_xXPatients must have an Eastern Cooperative Oncology Group (ECOG) performance status: ECOG of 0 or 1 including patients who are not surgical candidates due to comorbid conditionsXx_NEWLINE_xXParticipant must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group performance score (ECOG) ? 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2Xx_NEWLINE_xXSubject must have an Eastern Cooperative Oncology Group performance score of equal to or less than 2Xx_NEWLINE_xXMust have an Eastern Cooperative Oncology Group Performance Status score of 0, 1, or 2Xx_NEWLINE_xXSubjects must have Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2; if ECOG 2, they must also have a Charlson comorbidity index of =< 5Xx_NEWLINE_xXEastern Cooperative Oncology Group performance status (ECOG PS) 0 to 2. In case of ECOG PS 2, the PS has to be due to metastatic prostate cancer to the bone.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status (PS) Score 0 - 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score =< 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of less than or equal to (</=) 1Xx_NEWLINE_xXMust have Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 or 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 at the trial entry and an estimated life expectancy of at least 3 monthsXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance scale 0-2Xx_NEWLINE_xXParticipants must have a performance status of 0-2 based on Eastern Cooperative Oncology Group (ECOG) criteria; participants with a poor performance status (3-4) based solely on bone pain will be eligible, provided there is documentation to verify thisXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0, 1 or 2Xx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status =< 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score less than or equal to 1Xx_NEWLINE_xXAn Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 is requiredXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 to 2;Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of ? 1 at study entryXx_NEWLINE_xXEastern co-operative oncology group (ECOG) performance score <= 2 at screening.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of less than or equal to (</=) 1Xx_NEWLINE_xXHave performance status equal to or less than 2 on Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale is requiredXx_NEWLINE_xXEastern Cooperative Oncology Group Performance Status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status =< 1 for ages >= 16 or Lansky play >= 80% for ages =< 15Xx_NEWLINE_xXMaintain a performance status score of 0 to 2 according to the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXPatients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Score of 0-2.Xx_NEWLINE_xXWorld Health Organisation (WHO) or Eastern Cooperative Oncology Group (ECOG) Performance status 0-2.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXEaster Cooperative Oncology Group (ECOG) Performance Status of 0-2Xx_NEWLINE_xXThe Eastern Cooperative Oncology Group (ECOG)/World Health Organization (WHO) performance status of 2-3.or patients with chronic lymphocytic leukemia requiring treatment age >65 years at the time of signing informed consent and ECOG/WHO performance status of 0-1 and a CIRS or Charlson co-morbidity score of 2 or higher.Xx_NEWLINE_xXHave a performance status less than or equal to 1 for Dose Escalation (Part A) and less than or equal to 2 for Dose Confirmation (Parts B, C, D, E, F and G) on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score < 2 and life expectancy of at least 4 monthsXx_NEWLINE_xXSubject has an Eastern Cooperative Oncology Group (ECOG) performance score less than or equal to 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0, 1, or 2Xx_NEWLINE_xXPerformance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale and life expectancy > 3 monthsXx_NEWLINE_xXHave a performance status of equal to or less than 1 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score 2 orXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 or 1Xx_NEWLINE_xXMust have an Eastern Cooperative Oncology Group (ECOG) performance status score of ?2.Xx_NEWLINE_xXEaster Cooperative Oncology Group (ECOG) performance status of 0,1,or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of ? 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score between 0-1Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXKarnofsky performance score of >= 70 is required or Eastern Cooperative Oncology Group (ECOG) score, performance status (PS) = 0-2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1.Xx_NEWLINE_xXHave Eastern Cooperative Oncology Group (ECOG) performance status score 0-2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0-1Xx_NEWLINE_xXPatients must have an Eastern Cooperative Oncology Group (ECOG) score =< 3Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 0 or 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score 0-1Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0 or 1 if age less than (<) 71 years; ECOG status of 0 if age 71 to 75 yearsXx_NEWLINE_xXHas a performance status ? 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Co-Operative Group (ECOG) Performance Status (PS) Score 0 - 2Xx_NEWLINE_xXHas an Eastern Cooperative Oncology Group (ECOG) score of 0-1, with a life expectancy of >3 months;Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group Performance Scale (ECOG-PS) ?2Xx_NEWLINE_xXEastern Cooperative Oncology Group performance score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 in Parts 1 and 2 dose escalation and titration, and 0, 1, 2 in Part 3 dose expansionXx_NEWLINE_xXHave a performance status of ? 2 on the Eastern Cooperative Oncology Group (ECOG) scale in Part A and ? 1 on the ECOG scale in Part B.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of =< 1 within 14 days prior to dose 1 of mirvetuximab soravtansineXx_NEWLINE_xXAn Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2.Xx_NEWLINE_xXEastern Cooperative Oncology Group Performance Status score equal to or less than (<=) 2Xx_NEWLINE_xXPatient must have an Eastern Cooperative Oncology Group (ECOG) Performance Score of 0, 1, or 2Xx_NEWLINE_xXKarnofsky performance score of ? 60 (Eastern Cooperative Oncology Group [ECOG] performance score of 0, 1, or 2)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0, 1 or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1.Xx_NEWLINE_xXMale or female of >=18 years of age with the Eastern Cooperative Oncology Group (ECOG) performance status 0-1, Child-Pugh score of 5-7, and Life expectancy of 3 months or greater.Xx_NEWLINE_xXPerformance status of 0-2 based on the Eastern Cooperative Oncology Group (ECOG) criteria; patients with performance status 3 or 4, based solely on bone pain, are also eligible, provided that there is a source document to verify thisXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 at baseline;Xx_NEWLINE_xXECOG (Eastern Cooperative Oncology Group) performance score of 0 or 1Xx_NEWLINE_xXPatient has received a platinum containing regimen. Eastern Cooperative Oncology Group (ECOG) performance status 0-2. Radiographically-documented measureable disease.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0-2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of =< 3Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status: 0 or 1. NOTE: Subjects with a performance status of 2 can be enrolled if the subject's confinement to bed and inability to carry out work activities is due solely to cancer-related pain, as assessed by the Investigator.Xx_NEWLINE_xXWillingness to provide consent for biopsies positive or BRAF WT measurable disease, Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and adequate organ and marrow functionXx_NEWLINE_xXEastern Cooperative Oncology Group performance score of 0 or 1Xx_NEWLINE_xXPerformance Status score of 0 or 1 according to the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXECOG (Eastern Cooperative Oncology Group) Performance Score of 0 or 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 for Arm A and C subjects and 0-2 for Arm B.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 to 2.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0 to 2 in Part 1 and Part 2, participants enrolled in the extension/tail portion, Part 3 and Part 4 must have an ECOG performance status of 0 or 1Xx_NEWLINE_xXEastern Cooperative Group (ECOG) score ?2.Xx_NEWLINE_xXPerformance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXEastern Cooperative Oncology Group performance status score 0 or 1Xx_NEWLINE_xXThe patient has an Eastern Cooperative Oncology Group (ECOG) performance score (PS) of 0-2.Xx_NEWLINE_xXPatients must have an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1.Xx_NEWLINE_xXPerformance status 0-2 of the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status =< 2 for run-in phase; ECOG =< 1 for randomized phaseXx_NEWLINE_xXHistory/physical examination, including weight and assessment of Eastern Cooperative Oncology Group (ECOG) performance status, within 1 month of registrationXx_NEWLINE_xXEastern Cooperative Group (ECOG) status score of <=2.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXPatients with Eastern Cooperative Oncology Group (ECOG) score of <=2 at the time of screeningXx_NEWLINE_xXPerformance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) ScaleXx_NEWLINE_xXHave a performance status of less than or equal to 1 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXPatients must have a Gynecological Oncology Group (GOG) performance status of 0, 1 or 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 or for children < 10 years of age, Lansky of > 50 is requiredXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score of 0 or 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 or Karnofsky performance scale 50-100%Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0-2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of =< 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status ? 1. Patients with stable ECOG scores of 2 may be allowed with medical monitor approval.Xx_NEWLINE_xXPatients with performance status of =< 3 (Eastern Cooperative Oncology Group performance status scale, 3 only allowed if decline in status is deemed related to lymphoma and felt potentially reversible by the treating physician)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance status assessed between 0 and 2; performance status of 3 will be accepted if impairment is caused by DLBCL complications and improvement is expected once therapy is initiatedXx_NEWLINE_xXHave an ECOG (Eastern Cooperative Oncology Group) performance scale status of 0 – 2Xx_NEWLINE_xXPatient must have Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXPATIENT: Eastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 3 (symptomatic and in bed > 50% of the day)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 2 (symptomatic and in bed < 50% of day)Xx_NEWLINE_xXPatient is spending more than 50% of time out of bed on a daily basis, as measured by an Eastern Cooperative Oncology Group (ECOG) performance status rating of level 0, 1, or 2Xx_NEWLINE_xXAdult patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; pediatric patients must have Lansky score >= 60%Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0-1 during dose finding, 0-2 during MTD expansionXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXSubject must have an Eastern Cooperative Oncology Group (ECOG) performance score of ?2.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 and life expectancy of greater than 3 months.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale; an ECOG performance status of 2 is acceptable if the patient was ECOG 0/1 prior to curative intent therapy and is in the midst of recovery from curative intent therapyXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-2.Xx_NEWLINE_xXHave a performance status of 0 to 1 on the Eastern Cooperative Oncology Group scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 2 (symptomatic and in bed < 50% of the day)Xx_NEWLINE_xXAt the time of recruitment, a life expectancy of greater than 6 months and/or a Karnofsky performance status of 80 or above or an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score 0-2 at the time of randomizationXx_NEWLINE_xXThere will be no discrimination based on gender, race, creed, or ethnic background; Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance scale (KPS) will not be employedXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status of 0-1 (0=participant has either normal activity, 1= participant has some symptoms but is nearly full ambulatory)Xx_NEWLINE_xXEastern Cooperative Oncology Practice (Eastern Cooperative Oncology Group [ECOG]) score of 3 or belowXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 2 (symptomatic and in bed < 50% of the day)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score > 2 OR too ill to participate as judged by physician/in medical recordXx_NEWLINE_xXPatients who have an Eastern Cooperative Oncology Group (ECOG) performance status score greater than 2 at time of recruitmentXx_NEWLINE_xXSubject has a Karnofsky score <50, or a World Health Organization (WHO)/ Eastern Cooperative Oncology Group (ECOG) performance status ?3. Subjects who have a performance status of 3 may be considered for the study if the removal of their fluid would likely improve their performance score by 1 or more.Xx_NEWLINE_xXEaster Cooperative Oncology Group (ECOG) performance status 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance status score of 0 to 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXParticipant must have an Eastern Cooperative Oncology Group (ECOG) Performance status of: 0 - 1 (dose escalation cohorts) or 0 - 2 (expansion cohorts)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) ranging from 0 (asymptomatic) to 2 (symptomatic and in bed > 50% of the day)Xx_NEWLINE_xXPatient must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group performance status of 0 or 1 as assessed within 21 days prior to randomization.Xx_NEWLINE_xXPerformance status 0 to 3 (Eastern Cooperative Oncology Group [ECOG] scale)Xx_NEWLINE_xXECOG (Eastern Cooperative Oncology Group) scale performance status 0-3Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 or 1Xx_NEWLINE_xXHave a World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance score =< 2 and life expectancy > 6 monthsXx_NEWLINE_xXKarnofsky Performance Status score ? 70% or Eastern Cooperative Oncology Group Performance Status score of 0 to 2.Xx_NEWLINE_xXPatients must have Eastern Cooperative Oncology Group (ECOG) performance status score of =< 2Xx_NEWLINE_xXPerformance status of 0-2 according to the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXEastern Cooperative Oncology Group Performance Scale (ECOG PS) of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (fully active or restricted only in physically strenuous activity)Xx_NEWLINE_xXPatients with Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) score ? 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status =< 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 to =< 2Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXSubject must have Eastern Cooperative Oncology Group performance score =< 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 to 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 to 2Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-1Xx_NEWLINE_xXHave a performance status of 0 - 2 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXThe patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 or, based on judgment of the treating medical oncologist, can tolerate imaging and at least 6 months of ETXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-2Xx_NEWLINE_xXHas an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 to 1 within 3 days prior to the first dose of study treatment.Xx_NEWLINE_xXAn Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 is requiredXx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave an Eastern Cooperative Oncology Group (ECOG) score of 0-1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 to 2Xx_NEWLINE_xXEaster Cooperative Oncology Group (ECOG) performance status 0 or 1Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-2.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0-2Xx_NEWLINE_xXEastern Co-operative Oncology Group (ECOG) performance status score of 0, 1, or 2Xx_NEWLINE_xXHave a performance status of ?2 on the Eastern Cooperative Oncology Group (ECOG) scaleXx_NEWLINE_xXHave a performance status of ?2 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXNon-metastatic GI cancers are eligible only if the Eastern Cooperative Oncology Group (ECOG) performance status is 2, 3, or 4 at the time of consent (although patients with locally advanced [stage III] and inoperable pancreatic cancers are eligible regardless of their performance status)Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance score of 0 or 1.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1.Xx_NEWLINE_xXEastern Co-Operative Group (ECOG) Performance Status (PS) of 0-1Xx_NEWLINE_xXMinimal limitations on activities of daily living as measured by Eastern Cooperative Oncology Group (ECOG) score of 0-1Xx_NEWLINE_xXHas an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1.Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXHave a performance status (PS) ?1 on the Eastern Cooperative Oncology Group (ECOG) scale.Xx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 0 to 2. (see Appendix A)Xx_NEWLINE_xXHas a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale.Xx_NEWLINE_xXHave a performance status of =< 1 Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xXEastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1Xx_NEWLINE_xXHave a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scaleXx_NEWLINE_xX